AstraZeneca | Investor Event Presentation Deck

Slide schematic 7/7

callout 1/1 list 4/4 source-note 1/1 title 1/1

Components 7

primary bullet bullet bullet bullet source-note headline

Tools 1

Problem Statement Canvas slide · 70%

list/bullet: Neoadjuvant cisplatin-based chemotherapy with radical cystectomy improves overall survival vs radical cystectomy alone and has been the recommended treatment for MIBC for the past 40 years, however, ~50% of

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

Includes references to clinical trials (CheckMate 274, AMBASSADOR, NIAGARA) and drug (Imfinzi).